BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26172301)

  • 21. Cloning of antizyme inhibitor, a highly homologous protein to ornithine decarboxylase.
    Murakami Y; Ichiba T; Matsufuji S; Hayashi S
    J Biol Chem; 1996 Feb; 271(7):3340-2. PubMed ID: 8631929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal structure of human ornithine decarboxylase at 2.1 A resolution: structural insights to antizyme binding.
    Almrud JJ; Oliveira MA; Kern AD; Grishin NV; Phillips MA; Hackert ML
    J Mol Biol; 2000 Jan; 295(1):7-16. PubMed ID: 10623504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ATP- and antizyme-dependent endoproteolysis of ornithine decarboxylase to oligopeptides by the 26 S proteasome.
    Tokunaga F; Goto T; Koide T; Murakami Y; Hayashi S; Tamura T; Tanaka K; Ichihara A
    J Biol Chem; 1994 Jul; 269(26):17382-5. PubMed ID: 8021237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antizyme family for regulating polyamines.
    Kahana C
    J Biol Chem; 2018 Nov; 293(48):18730-18735. PubMed ID: 30355739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of the differential antizyme-binding affinity of ornithine decarboxylase.
    Liu YC; Hsu DH; Huang CL; Liu YL; Liu GY; Hung HC
    PLoS One; 2011; 6(11):e26835. PubMed ID: 22073206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical factors determining dimerization of human antizyme inhibitor.
    Su KL; Liao YF; Hung HC; Liu GY
    J Biol Chem; 2009 Sep; 284(39):26768-77. PubMed ID: 19635796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of ornithine decarboxylase and regulation by its antizyme in Thermus thermophilus.
    Pantazaki AA; Anagnostopoulos CG; Lioliou EE; Kyriakidis DA
    Mol Cell Biochem; 1999 May; 195(1-2):55-64. PubMed ID: 10395069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antizyme 3 inhibits polyamine uptake and ornithine decarboxylase (ODC) activity, but does not stimulate ODC degradation.
    Snapir Z; Keren-Paz A; Bercovich Z; Kahana C
    Biochem J; 2009 Apr; 419(1):99-103, 1 p following 103. PubMed ID: 19076071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein degradation, the main hub in the regulation of cellular polyamines.
    Kahana C
    Biochem J; 2016 Dec; 473(24):4551-4558. PubMed ID: 27941031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteasome pathway operates for the degradation of ornithine decarboxylase in intact cells.
    Murakami Y; Tanahashi N; Tanaka K; Omura S; Hayashi S
    Biochem J; 1996 Jul; 317 ( Pt 1)(Pt 1):77-80. PubMed ID: 8694789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational changes in ornithine decarboxylase enable recognition by antizyme.
    Mitchell JL; Chen HJ
    Biochim Biophys Acta; 1990 Jan; 1037(1):115-21. PubMed ID: 2104755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Degradation of ornithine decarboxylase by the mammalian and yeast 26S proteasome complexes requires all the components of the protease.
    Elias S; Bercovich B; Kahana C; Coffino P; Fischer M; Hilt W; Wolf DH; Ciechanover A
    Eur J Biochem; 1995 Apr; 229(1):276-83. PubMed ID: 7744041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Filarial parasites possess an antizyme but lack a functional ornithine decarboxylase.
    Kurosinski MA; Lüersen K; Ndjonka D; Younis AE; Brattig NW; Liebau E
    Acta Trop; 2013 Jun; 126(3):167-76. PubMed ID: 23474393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human ornithine decarboxylase paralogue (ODCp) is an antizyme inhibitor but not an arginine decarboxylase.
    Kanerva K; Mäkitie LT; Pelander A; Heiskala M; Andersson LC
    Biochem J; 2008 Jan; 409(1):187-92. PubMed ID: 17900240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 20S proteasomal degradation of ornithine decarboxylase is regulated by NQO1.
    Asher G; Bercovich Z; Tsvetkov P; Shaul Y; Kahana C
    Mol Cell; 2005 Mar; 17(5):645-55. PubMed ID: 15749015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification, assay, and functional analysis of the antizyme inhibitor family.
    Kahana C
    Methods Mol Biol; 2011; 720():269-78. PubMed ID: 21318879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Degradation of ornithine decarboxylase: exposure of the C-terminal target by a polyamine-inducible inhibitory protein.
    Li X; Coffino P
    Mol Cell Biol; 1993 Apr; 13(4):2377-83. PubMed ID: 8455617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chloroform-induced multiple forms of ornithine decarboxylase: differential sensitivity of forms to enhancement by diethyl maleate and inhibition by ODC-antizyme.
    Savage RE; Nofzinger K; Bedell C; DeAngelo AB; Pereira MA
    J Toxicol Environ Health; 1989; 27(1):57-64. PubMed ID: 2724368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antizyme, a mediator of ubiquitin-independent proteasomal degradation.
    Coffino P
    Biochimie; 2001; 83(3-4):319-23. PubMed ID: 11295492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ubiquitin-independent, Proteasome-mediated targeted degradation of KRAS in pancreatic adenocarcinoma cells using an engineered ornithine decarboxylase/antizyme system.
    Ma Y; Xu J; Huang P; Bai X; Gao H
    IUBMB Life; 2019 Jan; 71(1):57-65. PubMed ID: 30347501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.